Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107850

Studies on “Big” Growth Hormone from Human Plasma and Pituitary

Donald R. Wright, A. David Goodman, and Kathleen D. Trimble

1Division of Endocrinology and Metabolism, Department of Medicine, Albany Medical College, Albany, New York 12208

Find articles by Wright, D. in: PubMed | Google Scholar

1Division of Endocrinology and Metabolism, Department of Medicine, Albany Medical College, Albany, New York 12208

Find articles by Goodman, A. in: PubMed | Google Scholar

1Division of Endocrinology and Metabolism, Department of Medicine, Albany Medical College, Albany, New York 12208

Find articles by Trimble, K. in: PubMed | Google Scholar

Published November 1, 1974 - More info

Published in Volume 54, Issue 5 on November 1, 1974
J Clin Invest. 1974;54(5):1064–1073. https://doi.org/10.1172/JCI107850.
© 1974 The American Society for Clinical Investigation
Published November 1, 1974 - Version history
View PDF
Abstract

Most of the immunoreactive growth hormone (IRGH) in human plasma elutes from Sephadex G-75 as “little” GH (LGH), mol wt 22,000, but 14-39% elutes earlier (“big” GH, BGH). In saline extracts of human pituitary, 11-17% of IRGH eluted as BGH. On gel filtration of pituitary and plasma BGH in 8 M urea, 59-81% ran as LGH, but when the remaining BGH was refiltered in urea, all ran as BGH. Thus there is a “urea-stable” and a “urea-labile” form of BGH. SImilarly, freezing and thawing converted over half of pituitary and plasma BGH to LGH, but when the “freeze-stable” BGH was again frozen, thawed, and refiltered, almost all ran as BGH. Urea-stable BGH was not dissociated by freezing, and most of the freeze-stable BGH was stable in urea, so the two forms are very similar or identical. Since 8 M urea and freezing dissociate peptides linked by noncovalent bonds, probably the BGH that is dissociated by urea and freezing consists of LGH bound noncovalently to another moiety, while in stable BGH the LGH is bound to another molecule by covalent or unusually strong noncovalent linkage. On centrifugation, the sedimentation of urea-stable BGH was consistent with a mol wt about twice that of LGH. Trypsinization of urea-stable BGH converted 36-59% to LGH, suggesting that some BGH may be a “prohormone” of LGH. On retrypsinization of the BGH that was not converted to LGH, only 13-24% converted, suggesting that there may be two forms of urea-stable BGH which vary in their response to trypsin.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1064
page 1064
icon of scanned page 1065
page 1065
icon of scanned page 1066
page 1066
icon of scanned page 1067
page 1067
icon of scanned page 1068
page 1068
icon of scanned page 1069
page 1069
icon of scanned page 1070
page 1070
icon of scanned page 1071
page 1071
icon of scanned page 1072
page 1072
icon of scanned page 1073
page 1073
Version history
  • Version 1 (November 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts